Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3422) 3422
Newsletter (48) 48
Book Chapter (9) 9
Publication (7) 7
Conference Proceeding (3) 3
Magazine Article (2) 2
Newspaper Article (2) 2
Transcript (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2337) 2337
life sciences & biomedicine (2235) 2235
humans (1815) 1815
colistin - pharmacology (1757) 1757
colistin (1742) 1742
anti-bacterial agents - pharmacology (1589) 1589
microbiology (1420) 1420
pharmacology & pharmacy (1344) 1344
infectious diseases (1154) 1154
microbial sensitivity tests (1077) 1077
antibiotics (647) 647
animals (646) 646
male (638) 638
female (594) 594
bacteria (565) 565
biological and medical sciences (553) 553
drug resistance (548) 548
medical sciences (506) 506
colistin - therapeutic use (481) 481
anti-bacterial agents - therapeutic use (474) 474
antibacterial agents (474) 474
acinetobacter baumannii - drug effects (440) 440
pharmacology. drug treatments (440) 440
middle aged (406) 406
drug resistance, multiple, bacterial (405) 405
drug resistance, bacterial (393) 393
adult (388) 388
escherichia coli - drug effects (386) 386
colistin - administration & dosage (385) 385
biochemical phenomena, metabolism, and nutrition (381) 381
antibiotics. antiinfectious agents. antiparasitic agents (379) 379
pseudomonas aeruginosa - drug effects (369) 369
drug resistance in microorganisms (366) 366
anti-bacterial agents - administration & dosage (333) 333
aged (327) 327
antimicrobial agents (310) 310
klebsiella pneumoniae - drug effects (310) 310
polycyclic compounds (287) 287
bacterial infections and mycoses (280) 280
acinetobacter infections - microbiology (269) 269
infections (261) 261
gram-negative bacteria (257) 257
research (252) 252
pneumonia (249) 249
bacterial proteins - genetics (248) 248
acinetobacter baumannii (247) 247
drug resistance, bacterial - genetics (247) 247
pharmacology (246) 246
carbapenems - pharmacology (244) 244
beta-lactamases - genetics (240) 240
lipids (239) 239
acinetobacter infections - drug therapy (237) 237
pseudomonas aeruginosa (237) 237
health aspects (233) 233
drug synergism (230) 230
escherichia coli (228) 228
e coli (227) 227
genes (226) 226
escherichia coli - genetics (213) 213
hospitals (210) 210
analysis (207) 207
infectious disease (207) 207
escherichia coli proteins - genetics (199) 199
pseudomonas infections - drug therapy (190) 190
colistin resistance (187) 187
acinetobacter baumannii - isolation & purification (186) 186
treatment outcome (186) 186
antimicrobial resistance (184) 184
gram-negative bacteria - drug effects (183) 183
drug therapy, combination (181) 181
polymyxins - pharmacology (181) 181
tigecycline (180) 180
escherichia coli - isolation & purification (174) 174
epidemiology (172) 172
immunology (170) 170
mcr-1 (170) 170
klebsiella pneumoniae - genetics (168) 168
colistin - adverse effects (166) 166
plasmids (163) 163
retrospective studies (162) 162
antibiotic resistance (161) 161
enterobacteriaceae - drug effects (160) 160
gram-negative bacterial infections - drug therapy (159) 159
nosocomial infections (158) 158
bacterial pneumonia (157) 157
pathogens (157) 157
polymyxins (156) 156
drug resistance, multiple, bacterial - genetics (154) 154
klebsiella pneumoniae - isolation & purification (154) 154
klebsiella infections - microbiology (153) 153
colistin - pharmacokinetics (152) 152
anti-bacterial agents - pharmacokinetics (151) 151
klebsiella pneumoniae (151) 151
chloramphenicol - pharmacology (148) 148
bacterial infections (147) 147
adolescent (145) 145
aged, 80 and over (144) 144
anti-bacterial agents - adverse effects (143) 143
drug resistance, microbial (143) 143
research article (142) 142
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3245) 3245
Japanese (80) 80
Russian (67) 67
French (59) 59
German (45) 45
Italian (34) 34
Spanish (25) 25
Portuguese (19) 19
Polish (8) 8
Czech (7) 7
Turkish (6) 6
Dutch (4) 4
Chinese (3) 3
Norwegian (2) 2
Romanian (2) 2
Swedish (2) 2
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Effects of microplate type and broth additives on microdilution MIC susceptibility assays
by Kavanagh, Angela and Ramu, Soumya and Gong, Yujing and Cooper, Matthew A and Blaskovich, Mark A.T
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 01/2019, Volume 63, Issue 1
Broth microdilution assay | Additive effects | MIC | Microtiter plate effects | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Polymyxin B - pharmacology | Trimethoprim - chemistry | Trimethoprim - pharmacology | Rifampin - chemistry | Escherichia coli - drug effects | Depsipeptides - pharmacology | Vancomycin - chemistry | Colistin - pharmacology | Polysorbates - pharmacology | Anti-Bacterial Agents - chemistry | Vancomycin - pharmacology | Escherichia coli - metabolism | Teicoplanin - pharmacology | Plastics - chemistry | Escherichia coli - growth & development | Lipoglycopeptides - pharmacology | Culture Media - chemistry | Lipoglycopeptides - chemistry | Microbial Sensitivity Tests - instrumentation | Teicoplanin - analogs & derivatives | Depsipeptides - chemistry | Polymyxin B - chemistry | Calcium - pharmacology | Colistin - chemistry | Methicillin-Resistant Staphylococcus aureus - drug effects | Oxacillin - pharmacology | Penicillin G - chemistry | Teicoplanin - chemistry | Ciprofloxacin - pharmacology | Aminoglycosides - chemistry | Factor Analysis, Statistical | Penicillin G - pharmacology | Methicillin-Resistant Staphylococcus aureus - growth & development | Methicillin-Resistant Staphylococcus aureus - metabolism | Culture Media - pharmacology | Ciprofloxacin - chemistry | Anti-Bacterial Agents - pharmacology | Oxacillin - chemistry | Rifampin - pharmacology | Aminoglycosides - pharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae by In Vitro Time-Kill Experiments
by T. Tängdén and R. A. Hickman and P. Forsberg and P. Lagerbäck and C. G. Giske and O. Cars
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2014, Volume 58, Issue 3, pp. 1757 - 1762
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Klebsiella pneumoniae - drug effects | Minocycline - pharmacology | Minocycline - analogs & derivatives | Aztreonam - pharmacology | Microbial Sensitivity Tests | Colistin - pharmacology | Aminoglycosides - administration & dosage | Drug Resistance, Multiple, Bacterial | Vancomycin - pharmacology | Minocycline - administration & dosage | Rifampin - administration & dosage | beta-Lactamases - metabolism | Vancomycin - administration & dosage | Thienamycins - administration & dosage | Fosfomycin - pharmacology | Ciprofloxacin - pharmacology | Colistin - administration & dosage | Thienamycins - pharmacology | Drug Synergism | Daptomycin - pharmacology | Aztreonam - administration & dosage | Fosfomycin - administration & dosage | Ciprofloxacin - administration & dosage | Anti-Bacterial Agents - pharmacology | Rifampin - pharmacology | Aminoglycosides - pharmacology | In Vitro Techniques | Anti-Bacterial Agents - administration & dosage | Daptomycin - administration & dosage | Index Medicus | Experimental Therapeutics | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Synergistic Effects between Conventional Antibiotics and 2-Aminoimidazole-Derived Antibiofilm Agents
by Steven A. Rogers and Robert W. Huigens III and John Cavanagh and Christian Melander
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2010, Volume 54, Issue 5, pp. 2112 - 2118
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Biofilms - drug effects | Enterococcus faecium - drug effects | Staphylococcus epidermidis - drug effects | Chlorides - pharmacology | Drug Resistance, Multiple | Escherichia coli - drug effects | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Tobramycin - pharmacology | Bacteria - drug effects | Imidazoles - chemistry | Drug Resistance, Bacterial | Imidazoles - pharmacology | Magnesium - pharmacology | Erythrocytes - drug effects | Drug Synergism | Triazoles - pharmacology | Calcium Chloride - pharmacology | Colistin - pharmacology | Novobiocin - pharmacology | Anti-Bacterial Agents - pharmacology | Acinetobacter baumannii - drug effects | Manganese Compounds - pharmacology | Index Medicus | Pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Pharmacology of polymyxins: New insights into an 'old class of antibiotics
by Velkov, Tony and Roberts, Kade D and Nation, Roger L and Thompson, Philip E and Li, Jian
Future microbiology, ISSN 1746-0913, 06/2013, Volume 8, Issue 6, pp. 711 - 724
pharmacokinetic/pharmacodynamic | polymyxin | lipid A | lipopolysaccharide | structure-activity relationship | colistin | resistance | Life Sciences & Biomedicine | Microbiology | Science & Technology | Polymyxins - therapeutic use | Humans | Models, Molecular | Polymyxins - pharmacokinetics | Gram-Negative Bacterial Infections - drug therapy | Structure-Activity Relationship | Polymyxins - chemistry | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | Polymyxins - pharmacology | Models, Biological | Anti-Bacterial Agents - chemistry | Drug Resistance, Multiple, Bacterial | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | Antibacterial activity
Journal Article
Details down arrow
5. Full Text Polymyxins for CNS infections: Pharmacology and neurotoxicity
by Velkov, Tony and Dai, Chongshan and Ciccotosto, Giuseppe D and Cappai, Roberto and Hoyer, Daniel and Li, Jian
Pharmacology & therapeutics (Oxford), ISSN 0163-7258, 01/2018, Volume 181, pp. 85 - 90
Multi-drug resistance | Neurotoxicity | Colistin | CNS infections | Polymyxins | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Injections, Spinal | Neuroprotective Agents - therapeutic use | Polymyxin B - administration & dosage | Colistin - pharmacokinetics | Polymyxin B - therapeutic use | Polymyxin B - adverse effects | Drug Resistance, Multiple - drug effects | Humans | Injections, Intraventricular | Colistin - administration & dosage | Gram-Negative Bacterial Infections - drug therapy | Polymyxin B - pharmacokinetics | Models, Biological | Colistin - therapeutic use | Colistin - adverse effects | Central Nervous System Infections - drug therapy | Drugs | Drug delivery systems | Neurosciences | Mortality | Aminoglycosides | Drug resistance | Antibacterial agents | Homeopathy | Materia medica and therapeutics | Vehicles | Therapeutics | Bacteria | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Effect of Subinhibitory Concentrations of Antibiotics on Intrachromosomal Homologous Recombination in Escherichia coli
by Elena López and Jesús Blázquez
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 08/2009, Volume 53, Issue 8, pp. 3411 - 3415
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Chromosomes, Bacterial - drug effects | Trimethoprim - pharmacology | Ceftazidime - pharmacology | Fosfomycin - pharmacology | Escherichia coli - drug effects | Tetracycline - pharmacology | Ciprofloxacin - pharmacology | Imipenem - pharmacology | Microbial Sensitivity Tests | Colistin - pharmacology | Escherichia coli - genetics | Gentamicins - pharmacology | Chloramphenicol - pharmacology | Recombination, Genetic - genetics | Ampicillin - pharmacology | Anti-Bacterial Agents - pharmacology | Rifampin - pharmacology | Recombination, Genetic - drug effects | Index Medicus | Mechanisms of Action | Physiological Effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text In vitro synergistic activity of antimicrobial agents in combination against clinical isolates of Colistin-resistant Acinetobacter baumannii
by Bae, Seongman and Kim, Min-Chul and Park, Su-Jin and Kim, Hee Sueng and Sung, Heungsup and Kim, Mi-Na and Kim, Sung-Han and Lee, Sang-Oh and Choi, Sang-Ho and Woo, Jun Hee and Kim, Yang Soo and Chong, Yong Pil
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 11/2016, Volume 60, Issue 11, pp. 6774 - 6779
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Pneumonia, Bacterial - microbiology | Ceftazidime - pharmacology | Acinetobacter Infections - pathology | Humans | Aztreonam - pharmacology | Thienamycins - pharmacology | Bacteremia - microbiology | Drug Synergism | Microbial Sensitivity Tests | Colistin - pharmacology | Vancomycin - pharmacology | Teicoplanin - pharmacology | Acinetobacter baumannii - isolation & purification | Anti-Bacterial Agents - pharmacology | Retrospective Studies | Rifampin - pharmacology | Acinetobacter baumannii - drug effects | Acinetobacter baumannii - growth & development | Bacteremia - pathology | Drug Resistance, Multiple, Bacterial - drug effects | Pneumonia, Bacterial - pathology | Drug Combinations | Acinetobacter Infections - microbiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effect of Pulmonary Surfactant on Antimicrobial Activity In Vitro
by R. Schwameis and Z. Erdogan-Yildirim and M. Manafi and M. A. Zeitlinger and S. Strommer and R. Sauermann
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2013, Volume 57, Issue 10, pp. 5151 - 5154
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Fluoroquinolones | Linezolid | Minocycline - pharmacology | Anti-Infective Agents - pharmacology | Minocycline - analogs & derivatives | Acetamides - pharmacology | Aza Compounds - pharmacology | Pulmonary Surfactants - pharmacology | Quinolines - pharmacology | Microbial Sensitivity Tests | Daptomycin - pharmacology | Animals | Carbapenems - pharmacology | Colistin - pharmacology | Oxazolidinones - pharmacology | Swine | Staphylococcus aureus - drug effects | Index Medicus | Pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Trends in Drug Resistance of Acinetobacter baumannii over a 10-year Period： Nationwide Data from the China Surveillance of Antimicrobial Resistance Program
by Lei Gao Yuan Lyu Yun Li
Chinese medical journal, ISSN 0366-6999, 2017, Volume 130, Issue 6, pp. 659 - 664
监控程序 | β-内酰胺类 | ICU病房 | 耐药性 | 抗菌素 | 临床实验室 | 鲍氏不动杆菌 | Nonsusceptibility | Acinetobacter baumannii | Extensive drug resistance | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Penicillanic Acid - pharmacology | Cefoperazone - pharmacology | Ceftazidime - pharmacology | Minocycline - pharmacology | Anti-Infective Agents - pharmacology | Humans | Sulbactam - pharmacology | Levofloxacin - pharmacology | Amikacin - pharmacology | Imipenem - pharmacology | Microbial Sensitivity Tests | Piperacillin - pharmacology | Colistin - pharmacology | China | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - drug effects | Cephalosporins - pharmacology | Penicillanic Acid - analogs & derivatives | Drug resistance in microorganisms | Anti-infective agents | Dosage and administration | Genetic aspects | Research | Drug therapy | Intensive care | Bacterial infections | Surveillance | Antibiotics | Laboratories | Antimicrobial agents | Pharmacology | Genomes | Gram-negative bacteria | Nosocomial infections | Drug resistance | Index Medicus | Extensive Drug Resistance | Original | Acinetobacter baumannii; Nonsusceptibility; Extensive Drug Resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Molecular Epidemiology of Clinical Isolates of Carbapenem-Resistant Acinetobacter spp. from Chinese Hospitals
by Hui Wang and Ping Guo and Hongli Sun and He Wang and Qiwen Yang and Minjun Chen and Yingchun Xu and Yuanjue Zhu
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2007, Volume 51, Issue 11, pp. 4022 - 4028
Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Blotting, Southern | Integrons - genetics | Humans | Molecular Sequence Data | Acinetobacter - drug effects | Microbial Sensitivity Tests | Carbapenems - pharmacology | Colistin - pharmacology | beta-Lactamases - genetics | Chloramphenicol - pharmacology | Acinetobacter Infections - microbiology | Cross Infection - epidemiology | beta-Lactamases - pharmacology | Acinetobacter - genetics | China - epidemiology | Electrophoresis, Gel, Pulsed-Field | Sequence Analysis, DNA | Imipenem - pharmacology | Bacterial Proteins - pharmacology | beta-Lactams - pharmacology | Hospitals | Molecular Epidemiology | Acinetobacter Infections - epidemiology | Cross Infection - microbiology | Acinetobacter - isolation & purification | Anti-Bacterial Agents - pharmacology | Rifampin - pharmacology | Aminoglycosides - pharmacology | Drug Resistance, Multiple, Bacterial - genetics | Index Medicus | Mechanisms of Resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals
by Falagas, M and Skalidis, T and Vardakas, K and Legakis, N and Tsiplakou, S and Papaioannou, V and Trikka-Graphakos, E and Charalampakis, N and Sereti, C and Lebessi, E and Bozavoutoglou, E and Vogiatzakis, E and Moraiti, H and Xanthaki, A and Toutouza, M and Fountoulis, K and Perivolioti, E and Kraniotaki, H and Bournia, M and Vourli, S and Peteinaki, E and Chatzipanagiotou, S and Ioannidis, A and Makri, A and Daskalaki, M and Staikou, E and Tzannetou, K and Prifti, H and Mentessidou, K and Maltezou, A and Platsouka, E and Skarmoutsou, N and Spiliopoulou, I and Christofidou, M and Falagas, M and Vardakas, K and Triarides, N and Legakis, N and Legakis, N and Skalidis, T and Falagas, M and Kyriakidou, M and Hellenic Cefiderocol Study Grp and Hellenic Cefiderocol Study Group and on behalf of the Hellenic Cefiderocol Study Group
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 6, pp. 1704 - 1708
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Klebsiella pneumoniae - isolation & purification | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Klebsiella pneumoniae - drug effects | Ceftazidime - pharmacology | Minocycline - pharmacology | Humans | Minocycline - analogs & derivatives | Acinetobacter baumannii - enzymology | Gram-Negative Bacteria - isolation & purification | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Inpatients | Carbapenems - pharmacology | Colistin - pharmacology | Pseudomonas aeruginosa - enzymology | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | beta-Lactamases - metabolism | Cephalosporins - pharmacology | Greece - epidemiology | Pseudomonas aeruginosa - drug effects | Thienamycins - pharmacology | Gram-Negative Bacteria - enzymology | Gram-Negative Bacteria - drug effects | Klebsiella pneumoniae - enzymology | Gram-Negative Bacterial Infections - epidemiology | Bacterial Proteins - metabolism | Anti-Bacterial Agents - pharmacology | Acinetobacter baumannii - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text In Vitro activities of ceftazidime-avibactam, aztreonam-avibactam, and a panel of older and contemporary antimicrobial agents against carbapenemase-producing gram-negative bacilli
by Vasoo, Shawn and Cunningham, Scott A and Cole, Nicolynn C and Kohner, Peggy C and Menon, Sanjay R and Krause, Kevin M and Harris, Kelly A and De, Partha P and Koh, Tse Hsien and Patel, Robin
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 12/2015, Volume 59, Issue 12, pp. 7842 - 7846
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Azabicyclo Compounds - pharmacology | Enterobacteriaceae - enzymology | Gene Expression | Ceftazidime - pharmacology | Fosfomycin - pharmacology | Minocycline - pharmacology | Humans | Minocycline - analogs & derivatives | Bacterial Proteins - genetics | Enterobacteriaceae - genetics | Aztreonam - pharmacology | Microbial Sensitivity Tests | Colistin - pharmacology | beta-Lactamases - classification | beta-Lactamases - genetics | Enterobacteriaceae - drug effects | Bacterial Proteins - metabolism | Anti-Bacterial Agents - pharmacology | Bacterial Proteins - classification | beta-Lactamases - metabolism | Drug Combinations | Enterobacteriaceae - growth & development | Index Medicus | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights